Sponsored by Pri-Med
Pharma
Duchenne community mourns patient death, but largely stands behind Elevidys gene therapy
A 16-year-old’s death has ignited a debate around gene therapy and led to a pause of European trials.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.